Menopause Market Size, Share, Growth Analysis, By Age Group(Premature Menopause, Early Menopause, Average Menopause, Late Menopause), By Treatment Type(Hormone Replacement therapy (HRT), Non-Hormone Medicines, Complementary & Alternative Therapies), By Application(Screening, Diagnosis), By End User(Hospital Diagnostic Centers, Specific Clinics, Others), By Region - Industry Forecast 2024-2031

Global Menopause Market was valued at USD 16.9 Billion in 2022 and is poised to grow from USD 17.8 Billion in 2023 to USD 26.97 Billion by 2031, at a CAGR of 5.33% during the forecast period (2024-2031). 

Menopause is a natural biological process that marks the end of a woman's reproductive years. It usually occurs between the ages of 45 and 55, and is characterized by the cessation of menstrual periods. During menopause, women may experience a range of symptoms, including hot flashes, night sweats, mood changes, and vaginal dryness. There is a growing market for nutritional supplements and other products that are designed to help women manage the symptoms of menopause. These products include herbal supplements, vitamins, minerals, and other dietary supplements, as well as over-the-counter and prescription medications. The global menopause market is expected to grow significantly in the coming years, driven by factors such as increasing awareness about the health benefits of nutritional supplements, growing demand for natural and organic products, and rising incidence of menopause-related health issues. Also, the menopause market is driven by a number of factors, including the aging of the global population, rising awareness of menopause-related health issues, and growing demand for natural and organic products. In addition, women are becoming more active and engaged in managing their health and wellness during menopause, which is driving the development of new products and services. 

The increasing prevalence of vasomotor and menopausal symptoms, such as night sweats and hot flashes, among women during the menopausal transition is anticipated to drive market growth. Menopausal symptoms, including mood swings, difficulty concentrating, and depression, are also associated with this phase. A study published in the International Journal of Applied & Basic Medical Research revealed that 36.7% of women reported hot flashes among the 87.7% experiencing menopausal symptoms. Anxiety was the most reported symptom at 80%, followed by sleep issues at 61.2%. While hormone replacement therapy remains the primary treatment for menopausal symptoms, particularly vasomotor symptoms, its use is associated with potential adverse effects such as vaginal bleeding, fractures, dementia, urinary incontinence, breast cancer, heart attack, blood clots, stroke, and colorectal cancer. Consequently, patients are increasingly seeking safer alternatives like plant-based products and dietary supplements. The pandemic negatively impacted the mental health of women, leading to hormonal imbalances and an exacerbation of vasomotor symptoms. Despite the initial adverse effects on the market, sales of over-the-counter pharmaceutical products and dietary supplements witnessed a surge in the third and fourth quarters of 2020. A study by the Council for Responsible Nutrition (CRN) in August 2020 reported an increase in dietary supplement usage during the pandemic. The growing demand for dietary supplements is expected to persist due to a shift in consumer preference toward nature-based alternatives over synthetic pharmaceutical products.

US Menopause Market is poised to grow at a sustainable CAGR for the next forecast year.